zuloous.blogg.se

Enfusion iconiq growth 150m
Enfusion iconiq growth 150m









The company generated positive operating cash flow in the second quarter.Īdjusted EBITDA and Adjusted EBITDA Margin are supplemental measures of our operating performance that are neither required by, nor presented in accordance with, GAAP, and our calculations thereof may not be comparable to similarly titled measures reported by other companies. Cash and cash equivalents were $57 million as of June 30, 2022.Earnings per share was $(0.03) for the second quarter.Net Dollar Retention Rate (NDR) excluding involuntary churn was 121.9% in the second quarter NDR including involuntary churn was 117.8%.Annual Recurring Revenue (ARR) for June 2022 was $148.7 million, up 38% year-over-year.Net income of $(4.1) million (including $7.7 million in stock-based compensation charges), compared to net income of $4.3 million during the same period in the prior year.Adjusted EBITDA Margin was 14.9% compared to 25.8% during the same period in the prior year.Adjusted EBITDA was $5.4 million compared to $6.8 million during the same period in the prior year.Income from Operations of $(3.9) million (including $7.7 million in stock-based compensation charges), compared to $5.9 million during the same period in the prior year.

enfusion iconiq growth 150m

Recurring subscription revenue accounts for 98% of total revenue. Total revenue grew to $36.5 million, up 38% year-over-year led by new client signings and growth from existing clients.











Enfusion iconiq growth 150m